Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
SEER
SELLSeer, Inc. · Healthcare · United States · $108M · Avg Vol: $3M/d
34
StockRankGet insider-trade alerts
Q
32
V
37
M
57
P/E (TTM)
—
ROE
-25.5%
D/E
0.1x
Dividend %
—
Loading 1Y...
PRICE (1Y)+14.5%
SMA 50SMA 200
Close
$1.97
RSI (14)
20.9
52W High
$2.41
From 52W High
0.8%
SCORE BREAKDOWN
Quality
32
ROIC
-26.6%26.3
ROE
-25.5%29.1
GP/Assets
2.5%15.7
Op. Margin
-617.8%9.5
FCF/Assets
-16.8%21.8
Piotroski
239.0
Int. Cover
—N/A
D/E Ratio
0.10x63.7
Current Ratio
17.73x93.9
Value
37
P/E (TTM)
—N/A
EV/EBITDA
0.5x25.0
P/FCF
—N/A
P/B
0.4x97.9
P/S
7.1x33.0
Div Yield
—N/A
Momentum
57
52W High %
82%73.3
RS 6M
-5%68.0
SMA 50/200
0.98x60.1
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+21%35.1
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$108M
P/E (Forward)
-2.0x
Gross Margin
48.7%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of SEER are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| SEER | Seer, Inc.(you) | $108M | 34 | SELL |
| RLYB | Rallybio Corporation | $87M | 34 | SELL |
| NRXS | NeurAxis, Inc. | $84M | 33 | SELL |
| VTVT | vTv Therapeutics Inc. | $121M | 39 | HOLD |
| CUE | Cue Biopharma, Inc. | $135M | 30 | SELL |
| ANTX | AN2 Therapeutics, Inc. | $177M | 35 | SELL |
| LONA | LeonaBio, Inc. | $69M | 30 | SELL |
| WHWK | Whitehawk Therapeutics, Inc. | $183M | 32 | SELL |
| ATRA | Atara Biotherapeutics, Inc. | $71M | 29 | SELL |
| NKTX | Nkarta, Inc. | $162M | 29 | SELL |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.6%